Page 4«..3456..10..»


Category Archives: Hypogonadism

Jury Punishes AbbVie for False Advertising in First MDL Verdict – Legal Examiner


Posted: September 6, 2017 at 1:50 pm

In June of 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed testosterone-replacement therapy (TRT) lawsuits into one court in the Northern District of Illinois. Continue reading

Posted in Hypogonadism | Comments Off on Jury Punishes AbbVie for False Advertising in First MDL Verdict – Legal Examiner

‘Bachelorette’ Star Michael Nance Died From Cocaine, Heroin & Pill Overdose – Radar Online


Posted: August 31, 2017 at 5:41 pm

Emily Maynards Bachelorette suitor Michael Nance died from a cocaine, heroin and pill overdose on May 29, RadarOnline.com can report. According to Texas Travis County Medical Examiner Office, the 31-year-old had cocaine, heroin, sedative clonazepam otherwise known as Klonopin and anticonvulsant gabapentin in his system, leading to multiple drug toxicity and accidental death. READ THE SHOCKING AUTOPSY REPORT In the shocking medical examiner report, doctors said Nance had demonstrated punctate needle puncture-like marks on his arms, and a history of opiate abuse, hypogonadism and anxiety. Continue reading

Posted in Hypogonadism | Comments Off on ‘Bachelorette’ Star Michael Nance Died From Cocaine, Heroin & Pill Overdose – Radar Online

Male hypogonadism – Treatment – Mayo Clinic


Posted: August 30, 2017 at 5:42 am

Treatment for adults Treatment for male hypogonadism depends on the cause and whether you’re concerned about fertility. Hormone replacement. For hypogonadism caused by testicular failure, doctors use male hormone replacement therapy (testosterone replacement therapy, or TRT). Continue reading

Posted in Hypogonadism | Comments Off on Male hypogonadism – Treatment – Mayo Clinic

Wives of 3 of 4 patients treated for hypogonadism conceive – Times of India


Posted: August 25, 2017 at 10:50 am

Nagpur: For the first time in the city, four patients have undergone treatment for infertility for male hypogonadism. They were put through a therapy conceptualized by endocrinologist Dr Pramod Gandhi following which three of their wives conceived. Continue reading

Posted in Hypogonadism | Comments Off on Wives of 3 of 4 patients treated for hypogonadism conceive – Times of India

Pipeline Landscape of Male Hypogonadism Covering Therapeutic Assessment and Drug Portfolio in 2017 – Digital Journal


Posted: August 17, 2017 at 1:48 pm

Report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. This press release was orginally distributed by SBWire Albany, NY — (SBWIRE) — 08/16/2017 — The topic of Hypogonadism can be an embarrassing subject for an affected male. Nevertheless, it’s important that any man battling the symptoms of Hypogonadism to get over his embarrassment and be taken care of by a medical professional. Continue reading

Posted in Hypogonadism | Comments Off on Pipeline Landscape of Male Hypogonadism Covering Therapeutic Assessment and Drug Portfolio in 2017 – Digital Journal

Testosterone therapy improves sexual functions – INDIA New England – India New England


Posted: August 17, 2017 at 1:48 pm

New York Long-term testosterone replacement therapy improves both sexual and urinary functions as well as quality of life for men suffering from a condition due to deficiency of the hormone, according to a study. Continue reading

Posted in Hypogonadism | Comments Off on Testosterone therapy improves sexual functions – INDIA New England – India New England

Lipocine resubmits NDA for LPCN 1021 in hypogonadism – The Pharma Letter (registration)


Posted: August 14, 2017 at 5:46 am

US specialty pharma firm Lipocine (Nasdaq: LPCN) has resubmitted a New Drug Application (NDA) for LPCN 1021, its oral testosterone product candidate for testosterone replacement therapy (TRT) in adult males for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism. Initial market reaction saw a 5.9% gain to $4.49 for the stock, but it closed Friday up just 0.7% at $4.7. Lipocine had previously submitted an NDA for LPCN 1021 and received a Complete Response Letter (CRL) from the US Food and Drug Administration in June 2016. Continue reading

Posted in Hypogonadism | Comments Off on Lipocine resubmits NDA for LPCN 1021 in hypogonadism – The Pharma Letter (registration)

Male Hypogonadism Sales Market Research Report 2017 to 2022 – The Donohue Report


Posted: August 14, 2017 at 5:46 am

Global Male Hypogonadism Sales Market Research Report 2017 to 2022 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Sales Market Research Report 2017 to 2022 – The Donohue Report

Male Hypogonadism Market Growth Forecast Analysis by … – Green Mountain Outlook


Posted: August 14, 2017 at 5:46 am

Global Male Hypogonadism Market Research Report provides insights of Male Hypogonadism industry over past 5 years and a forecast until 2022.Report studies the Male Hypogonadism Market status and future trend in global market, splits Male Hypogonadism by type and by applications, to fully and deeply research and reveal the market situation and future forecast. Male Hypogonadism Market report would come in handy to understand your competitors and give you an insight about sales; volumes, revenues in the Male Hypogonadism industry, assists in making strategic decisions. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Market Growth Forecast Analysis by … – Green Mountain Outlook

Global Male Hypogonadism Market 2017 Allergan Plc., Endo International Plc., Ferring, AbbVie Inc. – DailyCommerceNews


Posted: August 10, 2017 at 4:44 pm

Worldwide Male Hypogonadism Market 2017 presents a widespread and fundamental study of Male Hypogonadism industry along with the analysis of subjective aspects which will provide key business insights to the readers. Global Male Hypogonadism Market 2017 research report offers the analytical view of the industry by studying different factors like Male Hypogonadism market growth, consumption volume, market trends and Male Hypogonadism industry cost structures during the forecast period from 2017 to 2022. Continue reading

Posted in Hypogonadism | Comments Off on Global Male Hypogonadism Market 2017 Allergan Plc., Endo International Plc., Ferring, AbbVie Inc. – DailyCommerceNews

Page 4«..3456..10..»